Nouvelle cuisine: Platelets served with inflammation

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 5579-5587

  Kapur, Rick ^a,b   Zufferey, Anne ^a   Boilard, Eric ^c   Semple, John W ^a,b,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CHEMOKINE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TOLL LIKE RECEPTOR; HLA ANTIGEN CLASS 1; TRANSCRIPTOME;

ARTICLE; CYTOKINE RELEASE; ENVIRONMENTAL STRESS; HEMOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; TRANSCRIPTOMICS; ANIMAL; GENETICS; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM;

ANIMALS; BLOOD PLATELETS; CD40 LIGAND; CELL-DERIVED MICROPARTICLES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; THROMBOCYTOPENIA; TOLL-LIKE RECEPTORS; TRANSCRIPTOME;

EID: 84931362214     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500259     Document Type: Article

References (142)

1. Machlus, K. R., and J. E. Italiano, Jr. 2013. The incredible journey: From megakaryocyte development to platelet formation. J. Cell Biol. 201: 785-796.
2. Semple, J. W., J. E. Italiano, Jr., and J. Freedman. 2011. Platelets and the immune continuum. Nat. Rev. Immunol. 11: 264-274.
3. Youssefian, T., A. Drouin, J. M. Massé, J. Guichard, and E. M. Cramer. 2002. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99: 4021-4029.
4. McMorran, B. J., V. M. Marshall, C. de Graaf, K. E. Drysdale, M. Shabbar, G. K. Smyth, J. E. Corbin, W. S. Alexander, and S. J. Foote. 2009. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323: 797-800.
5. Wong, C. H., C. N. Jenne, B. Petri, N. L. Chrobok, and P. Kubes. 2013. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 14: 785-792.
6. Clark, S. R., A. C. Ma, S. A. Tavener, B. McDonald, Z. Goodarzi, M. M. Kelly, K. D. Patel, S. Chakrabarti, E. McAvoy, G. D. Sinclair, et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13: 463-469.
7. Sreeramkumar, V., J. M. Adrover, I. Ballesteros, M. I. Cuartero, J. Rossaint, I. Bilbao, M. Nácher, C. Pitaval, I. Radovanovic, Y. Fukui, et al. 2014. Neutrophils scan for activated platelets to initiate inflammation. Science 346: 1234-1238.
8. Boilard, E., P. A. Nigrovic, K. Larabee, G. F. Watts, J. S. Coblyn, M. E. Weinblatt, E. M. Massarotti, E. Remold-O'Donnell, R. W. Farndale, J. Ware, and D. M. Lee. 2010. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327: 580-583.
9. Weyrich, A. S., S. Lindemann, and G. A. Zimmerman. 2003. The evolving role of platelets in inflammation. J. Thromb. Haemost. 1: 1897-1905.
10. Levin, J. 2007. The evolution of mammalian platelets. In Platelets, 2nd Ed. A. D. Michelson, ed. Elsevier, Amsterdam, p. 3-22.
11. Davì, G., and C. Patrono. 2007. Platelet activation and atherothrombosis. N. Engl. J. Med. 357: 2482-2494.
12. Assinger, A. 2014. Platelets and infection - an emerging role of platelets in viral infection. Front. Immunol. 5: 649.
13. Flaujac, C., S. Boukour, and E. Cramer-Bordé. 2010. Platelets and viruses: an ambivalent relationship. Cell. Mol. Life Sci. 67: 545-556.
14. Yeaman, M. R. 2010. Bacterial-platelet interactions: virulence meets host defense. Future Microbiol. 5: 471-506.
15. Yeaman, M. R. 2010. Platelets in defense against bacterial pathogens. Cell. Mol. Life Sci. 67: 525-544.
16. Kerrigan, S. W., and D. Cox. 2010. Platelet-bacterial interactions. Cell. Mol. Life Sci. 67: 513-523.
17. Aiolfi, R., and G. Sitia. 2015. Chronic hepatitis B: role of anti-platelet therapy in inflammation control. Cell. Mol. Immunol. DOI: 10.1038/cmi.2014.124.
18. Dankert, J., J. van der Werff, S. A. Zaat, W. Joldersma, D. Klein, and J. Hess. 1995. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect. Immun. 63: 663-671.
19. Kraemer, B. F., R. A. Campbell, H. Schwertz, Z. G. Franks, A. Vieira de Abreu, K. Grundler, B. T. Kile, B. K. Dhakal, M. T. Rondina, W. H. Kahr, et al. 2012. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 120: 5014-5020.
20. Fuchs, T. A., A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier, D. D. Myers, Jr., S. K. Wrobleski, T. W. Wakefield, J. H. Hartwig, and D. D. Wagner. 2010. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA 107: 15880-15885.
21. Thomas, G. M., C. Carbo, B. R. Curtis, K. Martinod, I. B. Mazo, D. Schatzberg, S. M. Cifuni, T. A. Fuchs, U. H. von Andrian, J. H. Hartwig, et al. 2012. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 119: 6335-6343.
22. Demers, M., D. S. Krause, D. Schatzberg, K. Martinod, J. R. Voorhees, T. A. Fuchs, D. T. Scadden, and D. D. Wagner. 2012. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc. Natl. Acad. Sci. USA 109: 13076-13081.
23. Fuchs, T. A., J. J. Alvarez, K. Martinod, A. A. Bhandari, R. M. Kaufman, and D. D. Wagner. 2013. Neutrophils release extracellular DNA traps during storage of red blood cell units. Transfusion 53: 3210-3216.
24. Chen, G., D. Zhang, T. A. Fuchs, D. Manwani, D. D. Wagner, and P. S. Frenette. 2014. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood 123: 3818-3827.
25. Caudrillier, A., K. Kessenbrock, B. M. Gilliss, J. X. Nguyen, M. B. Marques, M. Monestier, P. Toy, Z. Werb, and M. R. Looney. 2012. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122: 2661-2671.
26. de Stoppelaar, S. F., C. van 't Veer, and T. van der Poll. 2014. The role of platelets in sepsis. Thromb. Haemost. 112: 666-677.
27. Gawaz, M., T. Dickfeld, C. Bogner, S. Fateh-Moghadam, and F. J. Neumann. 1997. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med. 23: 379-385.
28. Russwurm, S., J. Vickers, A. Meier-Hellmann, P. Spangenberg, D. Bredle, K. Reinhart, and W. Lösche. 2002. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 17: 263-268.
29. Sakamaki, F., A. Ishizaka, M. Handa, S. Fujishima, T. Urano, K. Sayama, H. Nakamura, M. Kanazawa, T. Kawashiro, M. Katayama, et al. 1995. Soluble form of P-selectin in plasma is elevated in acute lung injury. Am. J. Respir. Crit. Care Med. 151: 1821-1826.
30. Washington, A. V., S. Gibot, I. Acevedo, J. Gattis, L. Quigley, R. Feltz, A. De La Mota, R. L. Schubert, J. Gomez-Rodriguez, J. Cheng, et al. 2009. TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J. Clin. Invest. 119: 1489-1501.
31. de Stoppelaar, S. F., C. Van't Veer, F. E. van den Boogaard, R. Nieuwland, A. J. Hoogendijk, O. J. de Boer, J. J. Roelofs, and T. van der Poll. 2013. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. Thromb. Haemost. 110: 582-592.
32. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13: 11-16.
33. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
34. Andonegui, G., S. M. Kerfoot, K. McNagny, K. V. Ebbert, K. D. Patel, and P. Kubes. 2005. Platelets express functional Toll-like receptor-4. Blood 106: 2417-2423.
35. Cognasse, F., H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, and O. Garraud. 2005. Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 83: 196-198.
36. Aslam, R., E. R. Speck, M. Kim, A. R. Crow, K. W. Bang, F. P. Nestel, H. Ni, A. H. Lazarus, J. Freedman, and J. W. Semple. 2006. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107: 637-641.
37. Semple, J. W., R. Aslam, M. Kim, E. R. Speck, and J. Freedman. 2007. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood 109: 4803-4805.
38. Patrignani, P., C. Di Febbo, S. Tacconelli, V. Moretta, G. Baccante, M. G. Sciulli, E. Ricciotti, M. L. Capone, I. Antonucci, M. D. Guglielmi, et al. 2006. Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. Blood 107: 3572-3574.
39. Ståhl, A. L., M. Svensson, M. Mörgelin, C. Svanborg, P. I. Tarr, J. C. Mooney, S. L. Watkins, R. Johnson, and D. Karpman. 2006. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108: 167-176.
40. Zhang, G., J. Han, E. J. Welch, R. D. Ye, T. A. Voyno-Yasenetskaya, A. B. Malik, X. Du, and Z. Li. 2009. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J. Immunol. 182: 7997-8004.
41. Stohlawetz, P., C. C. Folman, A. E. von dem Borne, T. Pernerstorfer, H. G. Eichler, S. Panzer, and B. Jilma. 1999. Effects of endotoxemia on thrombopoiesis in men. Thromb. Haemost. 81: 613-617.
42. Pick, M., C. Perry, T. Lapidot, C. Guimaraes-Sternberg, E. Naparstek, V. Deutsch, and H. Soreq. 2006. Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. Blood 107: 3397-3406.
43. Jayachandran, M., G. J. Brunn, K. Karnicki, R. S. Miller, W. G. Owen, and V. M. Miller. 2007. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J. Appl. Physiol (1985) 102: 429-433.
44. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16: 111-135.
45. André, P., L. Nannizzi-Alaimo, S. K. Prasad, and D. R. Phillips. 2002. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106: 896-899.
46. Henn, V., S. Steinbach, K. Büchner, P. Presek, and R. A. Kroczek. 2001. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98: 1047-1054.
47. Hammwöhner, M., A. Ittenson, J. Dierkes, A. Bukowska, H. U. Klein, U. Lendeckel, and A. Goette. 2007. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp. Biol. Med. (Maywood) 232: 581-589.
48. Anand, S. X., J. F. Viles-Gonzalez, J. J. Badimon, E. Cavusoglu, and J. D. Marmur. 2003. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb. Haemost. 90: 377-384.
49. Elzey, B. D., N. W. Schmidt, S. A. Crist, T. P. Kresowik, J. T. Harty, B. Nieswandt, and T. L. Ratliff. 2008. Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood 111: 3684-3691.
50. Iannacone, M., G. Sitia, M. Isogawa, P. Marchese, M. G. Castro, P. R. Lowenstein, F. V. Chisari, Z. M. Ruggeri, and L. G. Guidotti. 2005. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat. Med. 11: 1167-1169.
51. Kissel, K., S. Berber, A. Nockher, S. Santoso, G. Bein, and H. Hackstein. 2006. Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 46: 818-827.
52. Diacovo, T. G., M. D. Catalina, M. H. Siegelman, and U. H. von Andrian. 1998. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. J. Exp. Med. 187: 197-204.
53. Diacovo, T. G., K. D. Puri, R. A. Warnock, T. A. Springer, and U. H. von Andrian. 1996. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273: 252-255.
54. von Hundelshausen, P., and C. Weber. 2007. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100: 27-40.
55. Elzey, B. D., J. Tian, R. J. Jensen, A. K. Swanson, J. R. Lees, S. R. Lentz, C. S. Stein, B. Nieswandt, Y. Wang, B. L. Davidson, and T. L. Ratliff. 2003. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19: 9-19.
56. Hachem, A., D. Yacoub, Y. Zaid, W. Mourad, and Y. Merhi. 2012. Involvement of nuclear factor κB in platelet CD40 signaling. Biochem. Biophys. Res. Commun. 425: 58-63.
57. Malaver, E., M. A. Romaniuk, L. P. D'Atri, R. G. Pozner, S. Negrotto, R. Benzadón, and M. Schattner. 2009. NF-kappaB inhibitors impair platelet activation responses. J. Thromb. Haemost. 7: 1333-1343.
58. Spinelli, S. L., A. E. Casey, S. J. Pollock, J. M. Gertz, D. H. McMillan, S. D. Narasipura, N. A. Mody, M. R. King, S. B. Maggirwar, C. W. Francis, et al. 2010. Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler. Thromb. Vasc. Biol. 30: 591-598.
59. Gambaryan, S., A. Kobsar, N. Rukoyatkina, S. Herterich, J. Geiger, A. Smolenski, S. M. Lohmann, and U. Walter. 2010. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J. Biol. Chem. 285: 18352-18363.
60. Karim, Z. A., J. Zhang, M. Banerjee, M. C. Chicka, R. Al Hawas, T. R. Hamilton, P. A. Roche, and S. W. Whiteheart. 2013. IκB kinase phosphorylation of SNAP-23 controls platelet secretion. Blood 121: 4567-4574.
61. Liu, F., S. Morris, J. Epps, and R. Carroll. 2002. Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Thromb. Res. 106: 199-203.
62. Ali, F. Y., S. J. Davidson, L. A. Moraes, S. L. Traves, M. Paul-Clark, D. Bishop-Bailey, T. D. Warner, and J. A. Mitchell. 2006. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. FASEB J. 20: 326-328.
63. Sahler, J., C. Woeller, S. Spinelli, N. Blumberg, and R. Phipps. 2012. A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling. J. Thromb. Haemost. 10: 2563-2572.
64. Akbiyik, F., D. M. Ray, K. F. Gettings, N. Blumberg, C. W. Francis, and R. P. Phipps. 2004. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 104: 1361-1368.
65. Moraes, L. A., K. E. Swales, J. A. Wray, A. Damazo, J. M. Gibbins, T. D. Warner, and D. Bishop-Bailey. 2007. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets. Blood 109: 3741-3744.
66. Shulman, N. R., R. H. Aster, H. A. Pearson, and M. C. Hiller. 1962. Immunoreactions involving platelet. VI. Reactions of maternal isoantibodies responsible for neonatal purpura. Differentiation of a second platelet antigen system. J. Clin. Invest. 41: 1059-1069.
67. Blumberg, N., D. Masel, T. Mayer, P. Horan, and J. Heal. 1984. Removal of HLA-A,B antigens from platelets. Blood 63: 448-450.
68. Kao, K. J., D. J. Cook, and J. C. Scornik. 1986. Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody. Blood 68: 627-632.
69. Kao, K. J. 1987. Plasma and platelet HLA in normal individuals: quantitation by competitive enzyme-linked immunoassay. Blood 70: 282-286.
70. Kao, K. J. 1988. Selective elution of HLA antigens and beta 2-microglobulin from human platelets by chloroquine diphosphate. Transfusion 28: 14-17.
71. Neumüller, J., M. Tohidast-Akrad, M. Fischer, and W. R. Mayr. 1993. Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the 'thrombocyte-specific' glycoproteins Ia/IIa, IIb, and IIb/IIIa. Vox Sang. 65: 223-231.
72. Ghio, M., P. Contini, C. Mazzei, S. Brenci, G. Barberis, G. Filaci, F. Indiveri, and F. Puppo. 1999. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 93: 1770-1777.
73. Gouttefangeas, C., M. Diehl, W. Keilholz, R. F. Hörnlein, S. Stevanović, and H. G. Rammensee. 2000. Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro. Blood 95: 3168-3175.
74. Aslam, R., E. R. Speck, M. Kim, J. Freedman, and J. W. Semple. 2008. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells. Transfusion 48: 1778-1786.
75. Zufferey, A., D. Schvartz, S. Nolli, J. L. Reny, J. C. Sanchez, and P. Fontana. 2014. Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules. J. Proteomics 101: 130-140.
76. Chapman, L. M., A. A. Aggrey, D. J. Field, K. Srivastava, S. Ture, K. Yui, D. J. Topham, W. M. Baldwin, III, and C. N. Morrell. 2012. Platelets present antigen in the context of MHC class I. J. Immunol. 189: 916-923.
77. Mazzucco, L., P. Borzini, and R. Gope. 2010. Platelet-derived factors involved in tissue repair-from signal to function. Transfus. Med. Rev. 24: 218-234.
78. Assoian, R. K., A. Komoriya, C. A. Meyers, D. M. Miller, and M. B. Sporn. 1983. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258: 7155-7160.
79. Andersson, P. O., D. Stockelberg, S. Jacobsson, and H. Wadenvik. 2000. A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann. Hematol. 79: 507-513.
80. Andersson, P. O., A. Olsson, and H. Wadenvik. 2002. Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 116: 862-867.
81. Blair, P., and R. Flaumenhaft. 2009. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 23: 177-189.
82. Gleissner, C. A. 2012. Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis. Front Physiol 3: 1.
83. Petersen, F., L. Bock, H. D. Flad, and E. Brandt. 1999. Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8. Blood 94: 4020-4028.
84. Brandt, E., F. Petersen, A. Ludwig, J. E. Ehlert, L. Bock, and H. D. Flad. 2000. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J. Leukoc. Biol. 67: 471-478.
85. Alam, R., P. A. Forsythe, S. Stafford, M. A. Lett-Brown, and J. A. Grant. 1992. Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J. Exp. Med. 176: 781-786.
86. Schall, T. J., K. Bacon, R. D. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177: 1821-1826.
87. Italiano, J. E., Jr., J. L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavsky, S. Short, S. Ryeom, J. Folkman, and G. L. Klement. 2008. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111: 1227-1233.
88. Sehgal, S., and B. Storrie. 2007. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J. Thromb. Haemost. 5: 2009-2016.
89. White, G. C., II, and R. Rompietti. 2007. Platelet secretion: indiscriminately spewed forth or highly orchestrated? J. Thromb. Haemost. 5: 2006-2008.
90. Rowley, J. W., A. J. Oler, N. D. Tolley, B. N. Hunter, E. N. Low, D. A. Nix, C. C. Yost, G. A. Zimmerman, and A. S. Weyrich. 2011. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118: e101-e111.
91. Rowley, J. W., H. Schwertz, and A. S. Weyrich. 2012. Platelet mRNA: the meaning behind the message. Curr. Opin. Hematol. 19: 385-391.
92. Lood, C., S. Amisten, B. Gullstrand, A. Jönsen, M. Allhorn, L. Truedsson, G. Sturfelt, D. Erlinge, and A. A. Bengtsson. 2010. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: upregulation of the type I interferon system is strongly associated with vascular disease. Blood 116: 1951-1957.
93. Healy, A. M., M. D. Pickard, A. D. Pradhan, Y. Wang, Z. Chen, K. Croce, M. Sakuma, C. Shi, A. C. Zago, J. Garasic, et al. 2006. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113: 2278-2284.
94. Goodall, A. H., P. Burns, I. Salles, I. C. Macaulay, C. I. Jones, D. Ardissino, B. de Bono, S. L. Bray, H. Deckmyn, F. Dudbridge, et al; Bloodomics Consortium. 2010. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood 116: 4646-4656.
95. Simon, L. M., L. C. Edelstein, S. Nagalla, A. B. Woodley, E. S. Chen, X. Kong, L. Ma, P. Fortina, S. Kunapuli, M. Holinstat, et al. 2014. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 123: e37-e45.
96. Edelstein, L. C., L. M. Simon, R. T. Montoya, M. Holinstat, E. S. Chen, A. Bergeron, X. Kong, S. Nagalla, N. Mohandas, D. E. Cohen, et al. 2013. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat. Med. 19: 1609-1616.
97. Plé, H., M. Maltais, A. Corduan, G. Rousseau, F. Madore, and P. Provost. 2012. Alteration of the platelet transcriptome in chronic kidney disease. Thromb. Haemost. 108: 605-615.
98. McManus, D. D., L. M. Beaulieu, E. Mick, K. Tanriverdi, M. G. Larson, J. F. Keaney, Jr., E. J. Benjamin, and J. E. Freedman. 2013. Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 33: 2666-2673.
99. Freedman, J. E., M. G. Larson, K. Tanriverdi, C. J. O'Donnell, K. Morin, A. S. Hakanson, R. S. Vasan, A. D. Johnson, M. D. Iafrati, and E. J. Benjamin. 2010. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 122: 119-129.
100. Raghavachari, N., X. Xu, A. Harris, J. Villagra, C. Logun, J. Barb, M. A. Solomon, A. F. Suffredini, R. L. Danner, G. Kato, et al. 2007. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115: 1551-1562.
101. Risitano, A., L. M. Beaulieu, O. Vitseva, and J. E. Freedman. 2012. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 119: 6288-6295.
102. Clancy, L., and J. E. Freedman. 2014. New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer. J. Thromb. Thrombolysis 37: 12-16.
103. Laffont, B., A. Corduan, H. Plé, A. C. Duchez, N. Cloutier, E. Boilard, and P. Provost. 2013. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 122: 253-261.
104. Gidlöf, O., M. van der Brug, J. Ohman, P. Gilje, B. Olde, C. Wahlestedt, and D. Erlinge. 2013. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 121: 3908-3917, S1-S26.
105. Landry, P., I. Plante, D. L. Ouellet, M. P. Perron, G. Rousseau, and P. Provost. 2009. Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 16: 961-966.
106. Burkhart, J. M., M. Vaudel, S. Gambaryan, S. Radau, U. Walter, L. Martens, J. Geiger, A. Sickmann, and R. P. Zahedi. 2012. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120: e73-e82.
107. Schubert, S., A. S. Weyrich, and J. W. Rowley. 2014. A tour through the transcriptional landscape of platelets. Blood 124: 493-502.
108. Wolf, P. 1967. The nature and significance of platelet products in human plasma. Br. J. Haematol. 13: 269-288.
109. Buzas, E. I., B. György, G. Nagy, A. Falus, and S. Gay. 2014. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol 10: 356-364.
110. Lötvall, J., A. F. Hill, F. Hochberg, E. I. Buzás, D. Di Vizio, C. Gardiner, Y. S. Gho, I. V. Kurochkin, S. Mathivanan, P. Quesenberry, et al. 2014. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3: 26913.
111. Arraud, N., R. Linares, S. Tan, C. Gounou, J. M. Pasquet, S. Mornet, and A. R. Brisson. 2014. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemost. 12: 614-627.
112. Morel, O., L. Jesel, J. M. Freyssinet, and F. Toti. 2011. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler. Thromb. Vasc. Biol. 31: 15-26.
113. Owens, A. P., III, and N. Mackman. 2011. Microparticles in hemostasis and thrombosis. Circ. Res. 108: 1284-1297.
114. Tersteeg, C., H. F. Heijnen, A. Eckly, G. Pasterkamp, R. T. Urbanus, C. Maas, I. E. Hoefer, R. Nieuwland, R. W. Farndale, C. Gachet, et al. 2014. FLow-induced PRotrusions (FLIPRs): a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ. Res. 114: 780-791.
115. Connor, D. E., T. Exner, D. D. Ma, and J. E. Joseph. 2010. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb. Haemost. 103: 1044-1052.
116. Perez-Pujol, S., P. H. Marker, and N. S. Key. 2007. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A 71: 38-45.
117. Cloutier, N., S. Tan, L. H. Boudreau, C. Cramb, R. Subbaiah, L. Lahey, A. Albert, R. Shnayder, R. Gobezie, P. A. Nigrovic, et al. 2013. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol. Med. 5: 235-249.
118. Nurden, A. T. 2011. Platelets, inflammation and tissue regeneration. Thromb. Haemost. 105(Suppl. 1): S13-S33.
119. Reid, V. L., and N. R. Webster. 2012. Role of microparticles in sepsis. Br. J. Anaesth. 109: 503-513.
120. György, B., T. G. Szabó, L. Turiák, M. Wright, P. Herczeg, Z. Lédeczi, A. Kittel, A. Polgár, K. Tóth, B. Dérfalvi, et al. 2012. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS ONE 7: e49726.
121. Rousseau, M., C. Belleannee, A. C. Duchez, N. Cloutier, T. Levesque, F. Jacques, J. Perron, P. A. Nigrovic, M. Dieude, M. J. Hebert, et al. 2015. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS ONE 10: e0116812.
122. Gitz, E., A. Y. Pollitt, J. J. Gitz-Francois, O. Alshehri, J. Mori, S. Montague, G. B. Nash, M. R. Douglas, E. E. Gardiner, R. K. Andrews, et al. 2014. CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood 124: 2262-2270.
123. Boilard, E., P. Blanco, and P. A. Nigrovic. 2012. Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol 8: 534-542.
124. Mott, P. J., and A. H. Lazarus. 2013. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis. PLoS ONE 8: e65805.
125. Brown, G. T., and T. M. McIntyre. 2011. Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles. J. Immunol. 186: 5489-5496.
126. Boilard, E., G. Paré, M. Rousseau, N. Cloutier, I. Dubuc, T. Lévesque, P. Borgeat, and L. Flamand. 2014. Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation. Blood 123: 2854-2863.
127. Sun, D., N. I. Popescu, B. Raisley, R. S. Keshari, G. L. Dale, F. Lupu, and K. M. Coggeshall. 2013. Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement. Blood 122: 571-579.
128. Boudreau, L. H., A. C. Duchez, N. Cloutier, D. Soulet, N. Martin, J. Bollinger, A. Paré, M. Rousseau, G. S. Naika, T. Lévesque, et al. 2014. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 124: 2173-2183.
129. Ray, D. M., S. L. Spinelli, S. J. Pollock, T. I. Murant, J. J. O'Brien, N. Blumberg, C. W. Francis, M. B. Taubman, and R. P. Phipps. 2008. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb. Haemost. 99: 86-95.
130. Garcia, B. A., D. M. Smalley, H. Cho, J. Shabanowitz, K. Ley, and D. F. Hunt. 2005. The platelet microparticle proteome. J. Proteome Res. 4: 1516-1521.
131. Dasgupta, S. K., H. Abdel-Monem, P. Niravath, A. Le, R. V. Bellera, K. Langlois, S. Nagata, R. E. Rumbaut, and P. Thiagarajan. 2009. Lactadherin and clearance of platelet-derived microvesicles. Blood 113: 1332-1339.
132. Dasgupta, S. K., A. Le, T. Chavakis, R. E. Rumbaut, and P. Thiagarajan. 2012. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 125: 1664-1672.
133. Grozovsky, R., A. J. Begonja, K. Liu, G. Visner, J. H. Hartwig, H. Falet, and K. M. Hoffmeister. 2015. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat. Med. 21: 47-54.
134. Cines, D. B., A. Cuker, and J. W. Semple. 2014. Pathogenesis of immune thrombocytopenia. Presse Med. 43: e49-e59.
135. Zhang, W., M. A. Nardi, W. Borkowsky, Z. Li, and S. Karpatkin. 2009. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood 113: 4086-4093.
136. Wright, J. F., V. S. Blanchette, H. Wang, N. Arya, M. Petric, J. W. Semple, W. K. Chia, and J. Freedman. 1996. Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br. J. Haematol. 95: 145-152.
137. Takahashi, T., T. Yujiri, K. Shinohara, Y. Inoue, Y. Sato, Y. Fujii, M. Okubo, Y. Zaitsu, K. Ariyoshi, Y. Nakamura, et al. 2004. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 124: 91-96.
138. Li, Z., M. A. Nardi, and S. Karpatkin. 2005. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood 106: 572-576.
139. Chia, W. K., V. Blanchette, M. Mody, J. F. Wright, and J. Freedman. 1998. Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br. J. Haematol. 103: 1014-1022.
140. Asahi, A., T. Nishimoto, Y. Okazaki, H. Suzuki, T. Masaoka, Y. Kawakami, Y. Ikeda, and M. Kuwana. 2008. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 118: 2939-2949.
141. Tremblay, T., E. Aubin, R. Lemieux, and R. Bazin. 2007. Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice. Br. J. Haematol. 139: 297-302.
142. Kapur, R., K. M. Heitink-Polle, L. Porcelijn, A. E. Bentlage, M. C. Bruin, R. Visser, D. Roos, and R. B. Schasfoort, M. de Haas, C. E. van der Schoot, and G. Vidarsson. 2015. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia. Blood 125: 1793-1802.